Douglas Joseph, D.O.

Douglas E. Joseph, DO, RVT, is a Staff Physician and Director of the Carotid Intimal Medial Thickness (CIMT) Core Lab in the Department of Cardiovascular Medicine Section of Vascular Medicine, Heart and Vascular Institute, Cleveland Clinic. He is also the Outpatient Department Director and Continuing Quality Improvement Officer.
 
Dr. Joseph’s clinical duties include consultative services of hospitalized and outpatient clinic patients and interpretation of non-invasive vascular imaging. Educational activities include initiating a sclerotherapy training program in 2006; presenting lectures for grand rounds; conducting hospital teaching rounds and facilitating journal club.

Some of Dr. Joseph’s specialty interests include varicose and spider veins, venous insufficiency and the swollen limb. Dr. Joseph’s research interests include venous thrombosis, pseudoaneurysms and use of CIMT to assess pre-clinical atherosclerosis.
 
He is principal or co-investigator on multiple clinical trials including STAMPEDE, WALK, and CRESCENDO. He has authored or coauthored several publications including a supplement on peripheral arterial disease, the diagnosis and treatment of heparin induced thrombocytopenia and a book chapter on venous thromboembolic disease.
 
After receiving his medical degree from Des Moines University, Dr. Joseph completed residency training in Internal Medicine at St. Vincent Mercy Medical Center, Toledo, Ohio, and a fellowship in Vascular Medicine at Cleveland Clinic before joining the Cleveland Clinic in 2004. He is board-certified in internal medicine and vascular medicine and is a registered vascular technologist.

Venous thromboembolic disease, hypercoagulable conditions, peripheral arterial disease, risk factor modification, lymphedema, leg swelling, leg ulcers, varicose veins, spider veins and vascular ultrasound.

• The Society for Vascular Medicine
• The American College of Phlebology
• The American Medical Association
• The American Osteopathic Association

Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/5/2008, Dr. Joseph has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)